Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GE-145 vs Iohexol in Coronary Angiography
jRCT2080222341Phase 2
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ioforminol in coronary arteriosclerosis (2 arms), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
ioforminol
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on jRCT2080222341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222341.